62979aa7dee5b231693653.png
Frontiers | Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study
VIRUS EPSTEIN-BARR (VCA IgG) - Analisi Papagni
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis | Science
Positive Correlation between Epstein-Barr Virus Viral Load and Anti-Viral Capsid Immunoglobulin G Titers Determined for Hodgkin's Lymphoma Patients and Their Relatives | Journal of Clinical Microbiology
Seroprevalence of Epstein-Barr Virus in HIV-Infected Patients, A Case Control Study | Journal of Kermanshah University of Medical Sciences | Full Text
Epstein-Barr Virus, EBV virus infection
VIRUS EPSTEIN-BARR (VCA IgG) - Analisi Papagni
Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections | Clinical Microbiology Reviews
Virus di Epstein-Barr - Euroimmun
VIDAS EBV panel, diagnosis of Mononucleosis | bioMérieux Clinical Diagnostics
Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus - ScienceDirect
Clinical values of multiple Epstein-Barr virus (EBV) serological biomarkers detected by xMAP technology | Journal of Translational Medicine | Full Text
Elecsys® EBV panel
Epstein-Barr virus (EBV) seropositivity and median antibody levels in... | Download Table
Ac Anti-Epstein Barr EBNA IgG, VCA IgG, VCA IgM | MedLife
Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands | SpringerLink
Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update. - Abstract - Europe PMC
Vaccines | Free Full-Text | An Absence of Epstein–Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm Vaccination | HTML
Epstein-Barr Virus (VCA) IgG and IgG Avidity ELISA - VIDIA | MoBiTec Molecular Biotechnology
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus | Nature Communications
Antibodies | Free Full-Text | EBNA1 IgM-Based Discrimination Between Rheumatoid Arthritis Patients, Systemic Lupus Erythematosus Patients and Healthy Controls | HTML
Test
a) eBV seropositivity rates by age cohorts in a large hospital... | Download Scientific Diagram
